
Watch the on-demand webinar
Devyser Thalassemia v2: The all-in-one NGS solution for alpha & beta thalassemia
Why watch this webinar?
Thalassemia genetic testing has long been complex and time-consuming, requiring multiple assays and extensive hands-on work. Devyser Thalassemia v2 is designed to change that. This next-generation sequencing (NGS) solution simplifies genetic profiling by integrating alpha and beta thalassemia detection—including SNV and CNV analysis, and beta modifiers—into a single, efficient assay.
Watch and learn how Devyser Thalassemia v2 can help your laboratory:
- Reduce workflow complexity with a streamlined NGS protocol
- Achieve rapid, comprehensive genetic results in a single test
- Detect structural variants with superior CNV analysis
- Minimize hands-on time and eliminate the need for bioinformatics expertise
Latest from the Devyser blog
View all

Devyser launches a new updated NGS assay to simplify thalassemia testing
Devyser has launched Devyser Thalassemia v2, a next-generation sequencing (NGS) solution designed...
Read More

Devyser Thalassemia achieves 99.9% sensitivity: Insights from a recent study
Thalassemia and hemoglobinopathies are among the most common genetic disorders worldwide, affecting...
Read More